182 related articles for article (PubMed ID: 18321241)
1. Alitretinoin: a comprehensive review.
Cheng C; Michaels J; Scheinfeld N
Expert Opin Investig Drugs; 2008 Mar; 17(3):437-43. PubMed ID: 18321241
[TBL] [Abstract][Full Text] [Related]
2. Alitretinoin.
Am J Health Syst Pharm; 2002 Feb; 59(4):333-4. PubMed ID: 11885395
[No Abstract] [Full Text] [Related]
3. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].
Aguayo-Leiva IR; Urrutia S; Jaén-Olasolo P
Actas Dermosifiliogr; 2011 Oct; 102(8):616-22. PubMed ID: 21354545
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of chronic hand dermatitis with 36 continuous months of alitretinoin administration: report of three cases.
Gulliver WP; Baker KA
J Cutan Med Surg; 2012; 16(4):267-71. PubMed ID: 22784520
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.
Miles SA; Dezube BJ; Lee JY; Krown SE; Fletcher MA; Saville MW; Kaplan L; Groopman J; Scadden DT; Cooley T; Von Roenn J; Friedman-Kien A;
AIDS; 2002 Feb; 16(3):421-9. PubMed ID: 11834954
[TBL] [Abstract][Full Text] [Related]
6. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC
Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156
[TBL] [Abstract][Full Text] [Related]
7. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B
J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343
[TBL] [Abstract][Full Text] [Related]
8. [Off-label use of alitretinoin].
Fritz K; Tiplica GS; Salavastru C; Onder M
Hautarzt; 2013 Oct; 64(10):748-51. PubMed ID: 24150823
[TBL] [Abstract][Full Text] [Related]
9. Alitretinoin (Panretin) gel 0.1%.
Rhoads J
J Assoc Nurses AIDS Care; 2001; 12(5):86-91. PubMed ID: 11565242
[TBL] [Abstract][Full Text] [Related]
10. [Alitretinoin: a new treatment option for chronic refractory hand eczema].
Molin S; Ruzicka T
Hautarzt; 2008 Sep; 59(9):703-4, 706-9. PubMed ID: 18704345
[TBL] [Abstract][Full Text] [Related]
11. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial.
Ruzicka T; Larsen FG; Galewicz D; Horváth A; Coenraads PJ; Thestrup-Pedersen K; Ortonne JP; Zouboulis CC; Harsch M; Brown TC; Zultak M
Arch Dermatol; 2004 Dec; 140(12):1453-9. PubMed ID: 15611422
[TBL] [Abstract][Full Text] [Related]
12. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial.
Kurie JM; Lotan R; Lee JJ; Lee JS; Morice RC; Liu DD; Xu XC; Khuri FR; Ro JY; Hittelman WN; Walsh GL; Roth JA; Minna JD; Hong WK
J Natl Cancer Inst; 2003 Feb; 95(3):206-14. PubMed ID: 12569142
[TBL] [Abstract][Full Text] [Related]
13. Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging.
Baumann L; Vujevich J; Halem M; Martin LK; Kerdel F; Lazarus M; Pacheco H; Black L; Bryde J
Cutis; 2005 Jul; 76(1):69-73. PubMed ID: 16144296
[TBL] [Abstract][Full Text] [Related]
14. Topical 0.1% alitretinoin gel for classic Kaposi sarcoma.
Morganroth GS
Arch Dermatol; 2002 Apr; 138(4):542-3. PubMed ID: 11939830
[No Abstract] [Full Text] [Related]
15. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
16. Alitretinoin.
Cheer SM; Foster RH
Am J Clin Dermatol; 2000; 1(5):307-14; discussion 315-6. PubMed ID: 11702321
[TBL] [Abstract][Full Text] [Related]
17. Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics.
Schmitt-Hoffmann AH; Roos B; Schoetzau A; Leese PT; Meyer I; van de Wetering J; Kovacs P
Expert Rev Clin Pharmacol; 2012 Jul; 5(4):373-88. PubMed ID: 22943117
[TBL] [Abstract][Full Text] [Related]
18. Alitretinoin--its use in intractable hand eczema and other potential indications.
Petersen B; Jemec GB
Drug Des Devel Ther; 2009 Sep; 3():51-7. PubMed ID: 19920921
[TBL] [Abstract][Full Text] [Related]
19. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
[TBL] [Abstract][Full Text] [Related]
20. Real-world experience with alitretinoin in a community dermatology practice setting in patients with chronic hand dermatitis.
Ham K; Maini P; Gooderham MJ
J Cutan Med Surg; 2014 Oct; 18(5):332-6. PubMed ID: 25186994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
